-
1.发明申请SYSTEMS AND METHODS FOR APPLYING A SELECTED TREATMENT AGENT INTO CONTACT WITH TISSUE 审中-公开将选择的治疗剂与组织接触的系统和方法公开(公告)号：US20120209144A1
公开(公告)日：2012-08-16
申请号：US13454842
申请日：2012-04-24
Applicant: DAVID S. UTLEY , John W. Gaiser , Rachel Croft
Inventor： DAVID S. UTLEY , John W. Gaiser , Rachel Croft
CPC classification number: A61B18/1492 , A61B18/1477 , A61B2018/00214 , A61B2018/00232 , A61B2018/00553 , A61B2018/00797 , A61B2018/00815 , A61B2018/1425 , A61M25/0084
Abstract: Systems and methods that treat disorders of the gastrointestinal tract by applying one or more treatment agents to tissue at or near the region where abnormal neurological symptoms or abnormal tissue conditions exist. The treatment agent is selected to either disrupt the abnormal nerve pathways and/or to alleviate the abnormal tissue conditions. The treatment agent can include at least one cytokine and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or as a neoadjuvent or adjuvant treatment modality.
Abstract translation: 通过将一种或多种治疗剂施用于存在异常神经症状或异常组织病状的区域处或附近的组织来治疗胃肠道疾病的系统和方法。 选择治疗剂以破坏异常神经通路和/或减轻异常组织状况。 治疗剂可以包括至少一种细胞因子和/或至少一种香草酸化合物以引起所需的组织应答。 系统和方法可以用作主要治疗方式，或作为新辅助治疗方式。
-
2.发明申请Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction 审中-公开用于将选定的治疗剂与组织接触以治疗括约肌功能障碍的系统和方法公开(公告)号：US20110071468A1
公开(公告)日：2011-03-24
申请号：US12927517
申请日：2010-11-17
Applicant: David S. Utley , John W. Gaiser , Rachel Croft
Inventor： David S. Utley , John W. Gaiser , Rachel Croft
IPC: A61M31/00
CPC classification number: A61B18/1477 , A61B1/31 , A61B18/02 , A61B18/08 , A61B18/1492 , A61B18/1815 , A61B18/20 , A61B2018/00214 , A61B2018/00232 , A61B2018/00267 , A61B2018/00482 , A61B2018/00553 , A61B2018/00797 , A61B2018/00815 , A61B2018/0091 , A61B2018/00916 , A61B2018/1861 , A61B2090/3782 , A61B2218/007
Abstract: Systems and methods apply a selected treatment agent or agents into contact with tissue at or in the region of a dysfunctional sphincter (in the case of GERD, fecal incontinence, or other dysfunctional sphincter disorders) to affect improved sphincter barrier function and/or to disrupt abnormal nerve pathways. The treatment agent can include at least one cytokine and/or at least one tissue bulking agent and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or applied as a supplementary treatment before; during or after a primary intervention.
Abstract translation: 系统和方法将选定的治疗剂或药剂与功能异常括约肌区域（或GERD，大便失禁或其他功能失调的括约肌疾病）区域或组织接触，以影响改善的括约肌屏障功能和/或破坏 异常神经通路。 处理剂可以包括至少一种细胞因子和/或至少一种组织填充剂和/或至少一种香草酸化合物以引起所需的组织应答。 系统和方法可以用作主要治疗方式，或作为补充治疗应用; 在主要干预期间或之后。
-
3.发明申请Unified systems and methods for controlling use and operation of a family of different treatment devices 有权用于控制不同处理装置的家庭的使用和操作的统一的系统和方法公开(公告)号：US20070294108A1
公开(公告)日：2007-12-20
申请号：US11895205
申请日：2007-08-23
Applicant: Jay Qin , Robin Bek , John Gaiser , Rachel Croft , Peter Muller , David Utley
Inventor： Jay Qin , Robin Bek , John Gaiser , Rachel Croft , Peter Muller , David Utley
IPC: G06Q50/00
CPC classification number: A61B18/00 , A61B18/12 , A61B18/1206 , A61B18/1477 , A61B18/1492 , A61B2017/00017 , A61B2017/00199 , A61B2017/00482 , A61B2018/00011 , A61B2018/00214 , A61B2018/00261 , A61B2018/00267 , A61B2018/00273 , A61B2018/00285 , A61B2018/00291 , A61B2018/00494 , A61B2018/0066 , A61B2018/00898 , A61B2018/1475 , A61B2218/002 , G06F19/00 , G06Q50/22
Abstract: Unified systems and methods enable control of the use and operation of a family of different treatment devices, to treat dysfunction in different regions of the body.
Abstract translation: 统一的系统和方法能够控制一系列不同治疗装置的使用和操作，以治疗身体不同区域的功能障碍。
-
公开(公告)号：US20070118108A1
公开(公告)日：2007-05-24
申请号：US11650079
申请日：2007-01-05
Applicant: Rachel Croft
Inventor： Rachel Croft
IPC: A61B18/14
CPC classification number: A61B18/1485 , A61B18/1477 , A61B2018/005 , A61B2018/1425 , A61B2018/1475
Abstract: Systems and methods treat hemorrhoids by introducing a treatment device into the anal canal to extend above a hemorrhoidal plexus and adjacent a tissue region containing blood vessels that feed the hemorrhoidal plexus. The systems and methods operate the treatment device to affect tissue morphology in the tissue region to occlude or otherwise reduce blood flow through the vessels.
Abstract translation: 系统和方法通过将治疗装置引入肛管以在痔疮丛上方延伸并且邻近包含供血痔丛的血管的组织区域来治疗痔疮。 系统和方法操作处理装置以影响组织区域中的组织形态以封闭或以其它方式减少通过血管的血液流动。
-
公开(公告)号：US09198705B2
公开(公告)日：2015-12-01
申请号：US13590027
申请日：2012-08-20
Applicant: Jay Qin , Robin Bek , John Gaiser , Rachel Croft , Peter Muller , David S Utley
Inventor： Jay Qin , Robin Bek , John Gaiser , Rachel Croft , Peter Muller , David S Utley
CPC classification number: A61B18/00 , A61B18/12 , A61B18/1206 , A61B18/1477 , A61B18/1492 , A61B2017/00017 , A61B2017/00199 , A61B2017/00482 , A61B2018/00011 , A61B2018/00214 , A61B2018/00261 , A61B2018/00267 , A61B2018/00273 , A61B2018/00285 , A61B2018/00291 , A61B2018/00494 , A61B2018/0066 , A61B2018/00898 , A61B2018/1475 , A61B2218/002 , G06F19/00 , G06Q50/22
Abstract: Unified systems and methods enable control of the use and operation of a family of different treatment devices, to treat dysfunction in different regions of the body.
-
Patent Agency Ranking
6.发明申请公开(公告)号：US20090082721A1
公开(公告)日：2009-03-26
申请号：US12313845
申请日：2008-11-25
Applicant: David S. Utley , John W. Gaiser , Rachel Croft
Inventor： David S. Utley , John W. Gaiser , Rachel Croft
IPC: A61M5/00
CPC classification number: A61B18/1477 , A61B1/31 , A61B18/12 , A61B18/1206 , A61B18/1485 , A61B18/1492 , A61B2018/00011 , A61B2018/00029 , A61B2018/00077 , A61B2018/00148 , A61B2018/00214 , A61B2018/00232 , A61B2018/00261 , A61B2018/00267 , A61B2018/00273 , A61B2018/00285 , A61B2018/00291 , A61B2018/00482 , A61B2018/00553 , A61B2018/00654 , A61B2018/0066 , A61B2018/00702 , A61B2018/00755 , A61B2018/00791 , A61B2018/00797 , A61B2018/00815 , A61B2018/00875 , A61B2018/00898 , A61B2018/0091 , A61B2018/00916 , A61B2018/046 , A61B2018/1425 , A61B2018/1475 , A61B2090/3782 , A61B2218/002 , A61B2218/007
Abstract: Systems and methods apply a selected treatment agent or agents into contact with tissue at or in the region of a dysfunctional sphincter (in the case of GERD, fecal incontinence, or other dysfunctional sphincter disorders) to affect improved sphincter barrier function and/or to disrupt abnormal nerve pathways. The treatment agent can include at least one cytokine and/or at least one tissue bulking agent and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or applied as a supplementary treatment before, during or after a primary intervention.
-
7.发明授权公开(公告)号：US07293563B2
公开(公告)日：2007-11-13
申请号：US10912268
申请日：2004-08-05
Applicant: David Utley , John W Gaiser , Rachel Croft
Inventor： David Utley , John W Gaiser , Rachel Croft
IPC: A61B19/00
CPC classification number: A61B18/1492 , A61B18/1477 , A61B2018/00214 , A61B2018/00232 , A61B2018/00553 , A61B2018/00797 , A61B2018/00815 , A61B2018/1425 , A61M25/0084
Abstract: Systems and methods that treat disorders of the gastrointestinal tract by applying one or more treatment agents to tissue at or near the region where abnormal neurological symptoms or abnormal tissue conditions exist. The treatment agent is selected to either disrupt the abnormal nerve pathways and/or to alleviate the abnormal tissue conditions. The treatment agent can include at least one cytokine and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or as a neoadjuvent or adjuvant treatment modality.
Abstract translation: 通过将一种或多种治疗剂施用于存在异常神经症状或异常组织病状的区域处或附近的组织来治疗胃肠道疾病的系统和方法。 选择治疗剂以破坏异常神经通路和/或减轻异常组织状况。 治疗剂可以包括至少一种细胞因子和/或至少一种香草酸化合物以引起所需的组织应答。 系统和方法可以用作主要治疗方式，或作为新辅助治疗方式。
-
8.发明申请Unified systems and methods for controlling use and operation of a family of different treatment devices 审中-公开用于控制不同处理装置的家庭的使用和操作的统一的系统和方法公开(公告)号：US20050033271A1
公开(公告)日：2005-02-10
申请号：US10916714
申请日：2004-08-12
Applicant: Jay Qin , Robin Bek , John Gaiser , Rachel Croft , Peter Muller , David Utley
Inventor： Jay Qin , Robin Bek , John Gaiser , Rachel Croft , Peter Muller , David Utley
IPC: A61B19/00 , A61B17/00 , A61B18/00 , A61B18/02 , A61B18/04 , A61B18/12 , A61B18/14 , A61B18/18 , A61F7/12 , A61N5/02
CPC classification number: A61B18/00 , A61B18/12 , A61B18/1206 , A61B18/1477 , A61B18/1492 , A61B2017/00017 , A61B2017/00199 , A61B2017/00482 , A61B2018/00011 , A61B2018/00214 , A61B2018/00261 , A61B2018/00267 , A61B2018/00273 , A61B2018/00285 , A61B2018/00291 , A61B2018/00494 , A61B2018/0066 , A61B2018/00898 , A61B2018/1475 , A61B2218/002 , G06Q50/22
Abstract: Unified systems and methods enable control of the use and operation of a family of different treatment devices, to treat dysfunction in different regions of the body.
Abstract translation: 统一的系统和方法能够控制一系列不同治疗装置的使用和操作，以治疗身体不同区域的功能障碍。
-
9.发明授权公开(公告)号：US06645201B1
公开(公告)日：2003-11-11
申请号：US09556169
申请日：2000-04-21
Applicant: David Utley , Scott West , John Gaiser , Rachel Croft
Inventor： David Utley , Scott West , John Gaiser , Rachel Croft
IPC: A61B1818
CPC classification number: A61B18/1477 , A61B1/31 , A61B18/1485 , A61B2018/00267 , A61B2018/00482 , A61B2018/00553 , A61B2018/00797 , A61B2018/0091 , A61B2018/00916 , A61B2018/046 , A61B2090/3782 , A61B2218/007
Abstract: A sphincter tissue region is treated using a support structure sized for advancement into the anal canal. At least one electrode is carried by the structure. A mechanism is coupled to the electrode to move the electrode between a first position retracted in the support structure and a second position extended from the support structure through surface tissue to penetrate a subsurface tissue region at or near a sphincter in the anal canal. A cable is coupled to the electrode to conduct energy for application by the electrode to form a lesion in the subsurface tissue region.
Abstract translation: 括约肌组织区域使用尺寸适合进入肛管的支撑结构来治疗。 该结构承载至少一个电极。 机构耦合到电极以在缩回到支撑结构中的第一位置和从支撑结构延伸穿过表面组织的第二位置之间移动电极，以穿透肛管内的括约肌处或附近的下表面组织区域。 电缆耦合到电极以传导电极施加的能量，以在地下组织区域中形成病变。
-
公开(公告)号：US09289906B2
公开(公告)日：2016-03-22
申请号：US13802043
申请日：2013-03-13
Applicant: Rachel Croft
Inventor： Rachel Croft
Abstract: In specific embodiments, a device for cutting hairs comprises a pair of opposing surfaces actuatable so that the hairs are capable of being held between the opposing surfaces with sufficient firmness to allow the hairs to be pulled taut without being cut. The device also includes a cutter actuatable independent of the opposing surfaces and configured to cut the hairs held between the opposing surfaces when the cutter is actuated.
Abstract translation: 在具体实施方案中，用于切割毛发的装置包括一对相对的表面，其可致动，使得毛发能够以足够的坚固度保持在相对的表面之间，以允许毛发被拉紧而不被切割。 该装置还包括可独立于相对表面致动的切割器，并且构造成当切割器被致动时切割保持在相对表面之间的毛发。
-
-
-
-
-
-
-
-
-
Search Results
29
records
(took 0.019 seconds)
